BACKGROUND:Laparoscopic surgery offers patients with rectal cancer short-term benefits and similar survival rates as open surgery. However, selecting patients who are suitable candidates for laparoscopic surgery is essential to prevent intra-operative conversion from laparoscopic to open surgery. Clinical and pathological variables were studied among patients who had converted laparoscopic surgeries within the COLOR II trial to improve patient selection for laparoscopic rectal cancer surgery. METHODS:Between January 20, 2004, and May 4, 2010, 1044 patients with rectal cancer enrolled in the COLOR II trial and were randomized to either laparoscopic or open surgery. Of 693 patients who had laparoscopic surgery, 114 (16 %) were converted to open surgery. Predictive factors were studied using multivariate analyses, and morbidity and mortality rates were determined. RESULTS: Factors correlating with conversion were as follows: age above 65 years (OR 1.9; 95 % CI 1.2-3.0: p = 0.003), BMI greater than 25 (OR 2.7; 95 % CI 1.7-4.3: p < 0.001), and tumor location more than 5 cm from the anal verge (OR 0.5; CI 0.3-0.9). Gender was not significantly related to conversion (p = 0.14). In the converted group, blood loss was greater (p < 0.001) and operating time was longer (p = 0.028) compared with the non-converted laparoscopies. Hospital stay did not differ (p = 0.06). Converted procedures were followed by more postoperative complications compared with laparoscopic or open surgery (p = 0.041 and p = 0.042, respectively). Mortality was similar in the laparoscopic and converted groups. CONCLUSIONS: Age above 65 years, BMI greater than 25, and tumor location between 5 and 15 cm from the anal verge were risk factors for conversion of laparoscopic to open surgery in patients with rectal cancer.
RCT Entities:
BACKGROUND: Laparoscopic surgery offers patients with rectal cancer short-term benefits and similar survival rates as open surgery. However, selecting patients who are suitable candidates for laparoscopic surgery is essential to prevent intra-operative conversion from laparoscopic to open surgery. Clinical and pathological variables were studied among patients who had converted laparoscopic surgeries within the COLOR II trial to improve patient selection for laparoscopic rectal cancer surgery. METHODS: Between January 20, 2004, and May 4, 2010, 1044 patients with rectal cancer enrolled in the COLOR II trial and were randomized to either laparoscopic or open surgery. Of 693 patients who had laparoscopic surgery, 114 (16 %) were converted to open surgery. Predictive factors were studied using multivariate analyses, and morbidity and mortality rates were determined. RESULTS: Factors correlating with conversion were as follows: age above 65 years (OR 1.9; 95 % CI 1.2-3.0: p = 0.003), BMI greater than 25 (OR 2.7; 95 % CI 1.7-4.3: p < 0.001), and tumor location more than 5 cm from the anal verge (OR 0.5; CI 0.3-0.9). Gender was not significantly related to conversion (p = 0.14). In the converted group, blood loss was greater (p < 0.001) and operating time was longer (p = 0.028) compared with the non-converted laparoscopies. Hospital stay did not differ (p = 0.06). Converted procedures were followed by more postoperative complications compared with laparoscopic or open surgery (p = 0.041 and p = 0.042, respectively). Mortality was similar in the laparoscopic and converted groups. CONCLUSIONS: Age above 65 years, BMI greater than 25, and tumor location between 5 and 15 cm from the anal verge were risk factors for conversion of laparoscopic to open surgery in patients with rectal cancer.
Entities:
Keywords:
Conversion; Laparoscopic surgery; Rectal cancer
Authors: Pierre J Guillou; Philip Quirke; Helen Thorpe; Joanne Walker; David G Jayne; Adrian M H Smith; Richard M Heath; Julia M Brown Journal: Lancet Date: 2005 May 14-20 Impact factor: 79.321
Authors: Mark Buunen; Ruben Veldkamp; Wim C J Hop; Esther Kuhry; Johannes Jeekel; Eva Haglind; Lars Påhlman; Miguel A Cuesta; Simon Msika; Mario Morino; Antonio Lacy; Hendrik J Bonjer Journal: Lancet Oncol Date: 2008-12-13 Impact factor: 41.316
Authors: Heidi Nelson; Daniel J Sargent; H Sam Wieand; James Fleshman; Mehran Anvari; Steven J Stryker; Robert W Beart; Michael Hellinger; Richard Flanagan; Walter Peters; David Ota Journal: N Engl J Med Date: 2004-05-13 Impact factor: 91.245
Authors: M Buunen; H J Bonjer; W C J Hop; E Haglind; G Kurlberg; J Rosenberg; A M Lacy; M A Cuesta; A D'Hoore; A Fürst; J F Lange; P Jess; O Bulut; P Poornoroozy; K Juul Jensen; M Mark Christensen; E Lundhus; H Ovesen; D Birch; I Iesalnieks; C Jäger; M Kreis; Y van riet; E van der Harst; M F Gerhards; W A Bemelman; B M E Hansson; P A Neijenhuis; H A Prins; C Balague; E Targarona; J A Luján Mompeán; J D Franco Osorio; F J Garcia Molina; S Skullman; Z Läckberg; U Kressner; P Matthiessen; S H Kim; A Alfredo Poza Journal: Dan Med Bull Date: 2009-05
Authors: A Agha; A Fürst; I Iesalnieks; S Fichtner-Feigl; N Ghali; D Krenz; M Anthuber; K W Jauch; P Piso; H J Schlitt Journal: Int J Colorectal Dis Date: 2008-04 Impact factor: 2.571
Authors: David G Jayne; Pierre J Guillou; Helen Thorpe; Philip Quirke; Joanne Copeland; Adrian M H Smith; Richard M Heath; Julia M Brown Journal: J Clin Oncol Date: 2007-07-20 Impact factor: 44.544
Authors: T W A Koedam; M Veltcamp Helbach; P M van de Ven; Ph M Kruyt; N T van Heek; H J Bonjer; J B Tuynman; C Sietses Journal: Tech Coloproctol Date: 2018-03-22 Impact factor: 3.781
Authors: Yongjin F Lee; Jeremy Albright; Warqaa M Akram; Juan Wu; Jane Ferraro; Robert K Cleary Journal: J Gastrointest Surg Date: 2018-02-15 Impact factor: 3.452
Authors: Maria Charalambides; Athina Mavrou; Thomas Jennings; Michael P Powar; James Wheeler; R Justin Davies; Nicola S Fearnhead; Constantinos Simillis Journal: Int J Colorectal Dis Date: 2021-10-26 Impact factor: 2.571
Authors: C L Sparreboom; N Komen; D Rizopoulos; H L van Westreenen; P G Doornebosch; J W T Dekker; A G Menon; J B Tuynman; F Daams; D Lips; W M U van Grevenstein; T M Karsten; J F Lange; A D'Hoore; A M Wolthuis Journal: Colorectal Dis Date: 2019-03-26 Impact factor: 3.788
Authors: Hamza Sekkat; Amine Souadka; Lise Courtot; Ali Rafik; Laila Amrani; Amine Benkabbou; Pierre Peyrafort; Urs Giger-Pabst; Elias Karam; Raouf Mohsine; Anass M Majbar; Mehdi Ouaissi Journal: BMC Surg Date: 2022-05-10 Impact factor: 2.102
Authors: Michael P M de Neree Tot Babberich; Julia T van Groningen; Evelien Dekker; Theo Wiggers; Michel W J M Wouters; Willem A Bemelman; Pieter J Tanis Journal: Surg Endosc Date: 2018-01-17 Impact factor: 4.584